• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含微粉化氯雷他定的口腔崩解聚合物薄膜技术——不同载药量对薄膜性质的影响

Technology of Orodispersible Polymer Films with Micronized Loratadine-Influence of Different Drug Loadings on Film Properties.

作者信息

Centkowska Katarzyna, Ławrecka Elżbieta, Sznitowska Malgorzata

机构信息

Department of Pharmaceutical Technology, Medical University of Gdansk, Hallera Str. 107, 80-416 Gdansk, Poland.

出版信息

Pharmaceutics. 2020 Mar 10;12(3):250. doi: 10.3390/pharmaceutics12030250.

DOI:10.3390/pharmaceutics12030250
PMID:32164345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7150835/
Abstract

The production of orodispersible films (ODFs) with suspended insoluble drug substances is still a challenge, mainly due to the difficulty associated with achieving a proper homogeneity and mechanical properties of the films. Hypromellose (HPMC) and a mixture of polyvinyl alcohol (AP) and povidone (PVP) were compared in terms of their suitability for ODFs incorporating suspended micronized loratadine (LO) in a concentration range of 10%-40%. In a planetary mixer (Thinky), a uniform dispersion of LO in an aqueous viscous casting solution was obtained. The suspended LO particles caused dose-dependent changes in the viscosity of the casting mass and affected the mechanical quality of ODFs. Drug concentrations higher than 30% reduced the film flexibility and tear resistance, depending on the polymer type. LO films with a thickness of 100 µm disintegrated within 60-100 s, with no significant influence of the LO content in the range 10%-30%. HPMC films, regardless of the drug concentration, met the pharmacopoeial requirements regarding the uniformity of the drug content. AP/PVP films were too elastic, and the drug content uniformity was not achieved. The conclusion is that, using an HPMC matrix, it is possible to obtain a high load of a poorly water-soluble drug (30% of dry film mass corresponds to a dose of 5 mg per 1.5 cm) in ODFs characterized by proper physical characteristics.

摘要

制备含有悬浮不溶性药物的口腔崩解片(ODF)仍然是一项挑战,主要是因为难以实现片剂的适当均匀性和机械性能。比较了羟丙甲纤维素(HPMC)以及聚乙烯醇(AP)和聚维酮(PVP)的混合物用于制备含10%-40%浓度范围的悬浮微粉化氯雷他定(LO)的ODF的适用性。在行星式搅拌机(Thinky)中,LO在水性粘性浇铸溶液中获得了均匀分散。悬浮的LO颗粒导致浇铸物料的粘度发生剂量依赖性变化,并影响ODF的机械质量。高于30%的药物浓度会降低薄膜的柔韧性和抗撕裂性,这取决于聚合物类型。厚度为100 µm的LO薄膜在60-100秒内崩解,10%-30%范围内的LO含量对此没有显著影响。无论药物浓度如何,HPMC薄膜均符合药典关于药物含量均匀性的要求。AP/PVP薄膜弹性过大,未实现药物含量均匀性。结论是,使用HPMC基质,可以在具有适当物理特性的ODF中获得高负载的难溶性药物(干膜质量的30%相当于每1.5 cm 5 mg的剂量)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/977a5459af77/pharmaceutics-12-00250-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/260e7d6331eb/pharmaceutics-12-00250-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/d7236f78f1f1/pharmaceutics-12-00250-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/53466007680e/pharmaceutics-12-00250-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/bead5cb95386/pharmaceutics-12-00250-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/3315c804e8d9/pharmaceutics-12-00250-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/463d6f570386/pharmaceutics-12-00250-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/4bcfcbbdf55d/pharmaceutics-12-00250-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/977a5459af77/pharmaceutics-12-00250-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/260e7d6331eb/pharmaceutics-12-00250-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/d7236f78f1f1/pharmaceutics-12-00250-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/53466007680e/pharmaceutics-12-00250-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/bead5cb95386/pharmaceutics-12-00250-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/3315c804e8d9/pharmaceutics-12-00250-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/463d6f570386/pharmaceutics-12-00250-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/4bcfcbbdf55d/pharmaceutics-12-00250-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9b/7150835/977a5459af77/pharmaceutics-12-00250-g008.jpg

相似文献

1
Technology of Orodispersible Polymer Films with Micronized Loratadine-Influence of Different Drug Loadings on Film Properties.含微粉化氯雷他定的口腔崩解聚合物薄膜技术——不同载药量对薄膜性质的影响
Pharmaceutics. 2020 Mar 10;12(3):250. doi: 10.3390/pharmaceutics12030250.
2
Incorporation of surface-modified dry micronized poorly water-soluble drug powders into polymer strip films.将表面改性的干燥微粉化水溶性差的药物粉末掺入聚合物条带薄膜中。
Int J Pharm. 2018 Jan 15;535(1-2):462-472. doi: 10.1016/j.ijpharm.2017.11.040. Epub 2017 Nov 21.
3
Development of orodispersible polymer films containing poorly water soluble active pharmaceutical ingredients with focus on different drug loadings and storage stability.含有低水溶性活性药物成分的口腔分散片聚合物薄膜的开发,重点在于不同的药物负载和存储稳定性。
Int J Pharm. 2015 Sep 30;493(1-2):134-45. doi: 10.1016/j.ijpharm.2015.07.032. Epub 2015 Jul 26.
4
Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.个体化药学治疗中的口溶膜:药剂学制剂的一种配方开发。
Int J Pharm. 2015 Jan 15;478(1):155-163. doi: 10.1016/j.ijpharm.2014.11.013. Epub 2014 Nov 7.
5
Increased drug load and polymer compatibility of bilayered orodispersible films.双层口腔分散片的载药量和聚合物相容性增加。
Eur J Pharm Sci. 2017 Sep 30;107:183-190. doi: 10.1016/j.ejps.2017.07.010. Epub 2017 Jul 12.
6
Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.儿童用瑞卡丁特里口溶膜的研制、体外和体内评价。
AAPS PharmSciTech. 2021 Jan 3;22(1):15. doi: 10.1208/s12249-020-01896-6.
7
Preparation and Evaluation of Caffeine Orodispersible Films: The Influence of Hydrotropic Substances and Film-Forming Agent Concentration on Film Properties.咖啡因口腔崩解膜的制备与评价:助溶剂和成膜剂浓度对膜性能的影响
Polymers (Basel). 2023 Apr 25;15(9):2034. doi: 10.3390/polym15092034.
8
Fabrication and Characterization of Orodispersible Composite Film from Hydroxypropylmethyl Cellulose-Crosslinked Carboxymethyl Rice Starch.羟丙基甲基纤维素交联羧甲基大米淀粉口腔崩解复合膜的制备与表征
Membranes (Basel). 2022 Jun 4;12(6):594. doi: 10.3390/membranes12060594.
9
A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.一种新的单位剂量方法用于口腔分散片的药物配制。
Int J Pharm. 2018 Mar 25;539(1-2):165-174. doi: 10.1016/j.ijpharm.2018.01.047. Epub 2018 Feb 27.
10
Impact of Mixing on Content Uniformity of Thin Polymer Films Containing Drug Micro-Doses.混合对含药物微剂量的聚合物薄膜含量均匀性的影响。
Pharmaceutics. 2021 May 29;13(6):812. doi: 10.3390/pharmaceutics13060812.

引用本文的文献

1
Exploring the interconnected properties of cannabidiol suspensions and orodispersible films.探索大麻二酚悬浮液和口腔崩解膜的相互关联特性。
Sci Rep. 2025 Jul 1;15(1):21564. doi: 10.1038/s41598-025-02859-2.
2
Development and Optimization of Oral Dissolution Films for Enhanced Delivery of Ebastine-Loaded Solid Lipid Nanoparticles.用于增强载依巴斯汀固体脂质纳米粒递送的口腔崩解膜的开发与优化
Int J Nanomedicine. 2025 May 30;20:6963-6981. doi: 10.2147/IJN.S521504. eCollection 2025.
3
Sublingual Fast-Dissolving Thin Films of Loratadine: Characterization, In Vitro and Ex Vivo Evaluation.

本文引用的文献

1
Anti-solvent Precipitation Method Coupled Electrospinning Process to Produce Poorly Water-Soluble Drug-Loaded Orodispersible Films.反溶剂沉淀法耦合静电纺丝工艺制备难溶性药物载口腔速溶膜。
AAPS PharmSciTech. 2019 Aug 5;20(7):273. doi: 10.1208/s12249-019-1464-2.
2
3D-printed electrospinning setup for the preparation of loratadine nanofibers with enhanced physicochemical properties.用于制备具有增强理化性能的氯雷他定纳米纤维的 3D 打印静电纺丝装置。
Int J Pharm. 2019 Aug 15;567:118455. doi: 10.1016/j.ijpharm.2019.118455. Epub 2019 Jun 21.
3
Development of a dosing device for individualized dosing of orodispersible warfarin films.
氯雷他定舌下速溶薄膜:表征、体外和离体评价
Polymers (Basel). 2024 Oct 17;16(20):2919. doi: 10.3390/polym16202919.
4
Enhancing Pharmacokinetics and Pharmacodynamics of Rosuvastatin Calcium through the Development and Optimization of Fast-Dissolving Films.通过开发和优化速溶膜提高瑞舒伐他汀钙的药代动力学和药效学
Pharmaceutics. 2023 Nov 19;15(11):2640. doi: 10.3390/pharmaceutics15112640.
5
Nanoemulsion-Based Orodispersible Film Formulation of Guava Leaf Oil for Inhibition of Oral Cancer Cells.基于纳米乳剂的番石榴叶油口腔崩解膜制剂对口腔癌细胞的抑制作用
Pharmaceutics. 2023 Nov 16;15(11):2631. doi: 10.3390/pharmaceutics15112631.
6
Hydroxypropyl Methylcellulose Orodispersible Film Containing Desloratadine for Geriatric Use: Formulation and Evaluation.羟丙甲纤维素速溶口腔贴片含地氯雷他定用于老年患者:制剂与评价。
Antiinflamm Antiallergy Agents Med Chem. 2023;22(2):79-91. doi: 10.2174/1871523022666230816090942.
7
Orodispersible Films-Current State of the Art, Limitations, Advances and Future Perspectives.口腔崩解片——当前的技术水平、局限性、进展及未来展望
Pharmaceutics. 2023 Jan 20;15(2):361. doi: 10.3390/pharmaceutics15020361.
8
Optimization of Multilayer Films Composed of Chitosan and Low-Methoxy Amidated Pectin as Multifunctional Biomaterials for Drug Delivery.壳聚糖和低甲氧基酰胺化果胶组成的多层膜作为多功能药物输送生物材料的优化。
Int J Mol Sci. 2022 Jul 22;23(15):8092. doi: 10.3390/ijms23158092.
9
Preparation of stable enteric folic acid-loaded microfiber using the electrospinning method.采用静电纺丝法制备稳定的载叶酸肠溶微纤维。
Iran J Basic Med Sci. 2022 Mar;25(3):405-413. doi: 10.22038/IJBMS.2022.61563.13625.
10
Orodispersible Films with Rupatadine Fumarate Enclosed in Ethylcellulose Microparticles as Drug Delivery Platform with Taste-Masking Effect.以富马酸卢帕他定为包封物、乙基纤维素微粒为载体的口腔崩解膜作为具有掩味作用的药物递送平台
Materials (Basel). 2022 Mar 14;15(6):2126. doi: 10.3390/ma15062126.
开发一种用于个体化给药的口服崩解型华法林薄膜的给药装置。
Int J Pharm. 2019 Apr 20;561:314-323. doi: 10.1016/j.ijpharm.2019.03.019. Epub 2019 Mar 13.
4
Inhibiting Surface Crystallization and Improving Dissolution of Amorphous Loratadine by Dextran Sulfate Nanocoating.硫酸葡聚糖纳米涂层抑制表面结晶并提高非晶态氯雷他定的溶出度。
J Pharm Sci. 2019 Jul;108(7):2391-2396. doi: 10.1016/j.xphs.2019.02.018. Epub 2019 Mar 1.
5
Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.基于模型的载药纳米口服膜崩解时间和溶出速率描述。
Eur J Pharm Sci. 2019 Apr 30;132:18-26. doi: 10.1016/j.ejps.2019.02.029. Epub 2019 Feb 20.
6
Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.将载有双氯芬酸的微丸纳入口腔分散片可实现其长效释放。
Int J Pharm. 2019 Jan 10;554:149-160. doi: 10.1016/j.ijpharm.2018.11.013. Epub 2018 Nov 7.
7
Design of a new disintegration test system for the evaluation of orally disintegrating films.新型崩解试验系统设计,用于评估口崩片。
Int J Pharm. 2018 Dec 20;553(1-2):281-289. doi: 10.1016/j.ijpharm.2018.10.049. Epub 2018 Oct 23.
8
Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.采用热熔挤出和溶剂浇铸相结合的方法制备具有延长药物释放性能的口腔分散片。
Eur J Pharm Biopharm. 2018 Aug;129:66-73. doi: 10.1016/j.ejpb.2018.05.023. Epub 2018 May 21.
9
Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.连续制造和固定剂量、多层口腔分散片的分析特性。
Eur J Pharm Sci. 2018 May 30;117:236-244. doi: 10.1016/j.ejps.2018.02.030. Epub 2018 Feb 27.
10
Incorporation of surface-modified dry micronized poorly water-soluble drug powders into polymer strip films.将表面改性的干燥微粉化水溶性差的药物粉末掺入聚合物条带薄膜中。
Int J Pharm. 2018 Jan 15;535(1-2):462-472. doi: 10.1016/j.ijpharm.2017.11.040. Epub 2017 Nov 21.